Injective (INJ) has surged 18% in the past week, with a 3.02% rise in the last 24 hours. INJ broke out of a descending channel and could climb from its current price of $22.14 to the channel’s peak at $29.84, marking a potential 33.07% gain. A downturn could see it retest the $18.14 level before resuming its upward trend.

Buying interest in INJ has increased, with the RSI at 65.80 and the MACD signaling a strong buy. Both indicators point to further price gains in the near term.

The OI-Weighted Funding Rate, now at 0.0056%, reflects growing market optimism, supporting the possibility of INJ reaching its $29.84 target.